1. Home
  2. UBX vs MXC Comparison

UBX vs MXC Comparison

Compare UBX & MXC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • UBX
  • MXC
  • Stock Information
  • Founded
  • UBX 2009
  • MXC 1972
  • Country
  • UBX United States
  • MXC United States
  • Employees
  • UBX N/A
  • MXC N/A
  • Industry
  • UBX Biotechnology: Pharmaceutical Preparations
  • MXC Oil & Gas Production
  • Sector
  • UBX Health Care
  • MXC Energy
  • Exchange
  • UBX Nasdaq
  • MXC Nasdaq
  • Market Cap
  • UBX 29.2M
  • MXC 23.5M
  • IPO Year
  • UBX 2018
  • MXC N/A
  • Fundamental
  • Price
  • UBX $2.22
  • MXC $12.09
  • Analyst Decision
  • UBX Strong Buy
  • MXC
  • Analyst Count
  • UBX 2
  • MXC 0
  • Target Price
  • UBX $7.00
  • MXC N/A
  • AVG Volume (30 Days)
  • UBX 483.8K
  • MXC 19.5K
  • Earning Date
  • UBX 11-04-2024
  • MXC 02-14-2025
  • Dividend Yield
  • UBX N/A
  • MXC 0.83%
  • EPS Growth
  • UBX N/A
  • MXC N/A
  • EPS
  • UBX N/A
  • MXC 0.57
  • Revenue
  • UBX N/A
  • MXC $6,926,917.00
  • Revenue This Year
  • UBX N/A
  • MXC N/A
  • Revenue Next Year
  • UBX $33.62
  • MXC N/A
  • P/E Ratio
  • UBX N/A
  • MXC $21.25
  • Revenue Growth
  • UBX N/A
  • MXC N/A
  • 52 Week Low
  • UBX $0.94
  • MXC $9.41
  • 52 Week High
  • UBX $3.10
  • MXC $16.52
  • Technical
  • Relative Strength Index (RSI)
  • UBX 61.12
  • MXC 51.51
  • Support Level
  • UBX $2.02
  • MXC $11.50
  • Resistance Level
  • UBX $2.42
  • MXC $12.14
  • Average True Range (ATR)
  • UBX 0.31
  • MXC 0.62
  • MACD
  • UBX 0.01
  • MXC -0.06
  • Stochastic Oscillator
  • UBX 39.61
  • MXC 35.12

About UBX Unity Biotechnology Inc.

Unity Biotechnology Inc designs therapeutics that prevent, halt, and reverse various diseases of aging. The company focuses on clearing senescent cells, and creating senolytic medicines. Its medicines target vulnerabilities unique to senescent cells to clear those cells from the human body while leaving normal cells unaffected. The firm focuses on age-associated diseases such as osteoarthritis, eye diseases, and pulmonary diseases. Its drug candidates include, UBX1325 is being developed for age-related diseases of the eye, including diabetic macular edema, or DME, UBX2089, which is a circulating hormone primarily produced in the kidneys and choroid plexus of the brain, which is being researched for multiple neurology indications, and UBX2050.

About MXC Mexco Energy Corporation

Mexco Energy Corporation is an independent oil and gas company. It is engaged in the exploration, development, and production of natural gas and crude oil properties located in the United States. The company carried out its operation in the Permian Basin of West Texas. It is focusing on two primary areas, the Delaware Basin located in the Western portion of the Permian Basin including Lea and Eddy Counties, New Mexico and Loving County, Texas, and the Midland Basin located in the Eastern portion of the Permian Basin including Reagan, Upton, Midland, Martin, Howard, and Glasscock Counties, Texas. The company generates revenue from Oil sales, Natural gas sales, oil and gas royalty interests.

Share on Social Networks: